{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:57:51Z","timestamp":1761058671639},"reference-count":22,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2007,4,28]],"date-time":"2007-04-28T00:00:00Z","timestamp":1177718400000},"content-version":"vor","delay-in-days":8152,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Allergy"],"published-print":{"date-parts":[[1985,1]]},"abstract":"<jats:p>Thirty\u2010eight patients with chronic asthma requiring continuous oral corticosteroid treatment took part in a 2\u2010year study. Budesonide, a new inhalation steroid with high topical activity and low systemic effects, was given in stepwise increasing doses from 200 \u03bcg daily up to 800\u20131600 \u03bcg daily and prednisolone doses were decreased gradually on an individual basis. After 2 years, 18 patients had been able to cease oral prednisolone treatment, 11 had decreased the dose by  50%, three by  50% and two patients had increased their dose. At the end of the study the majority of patients (26) were using 800 ng budesonide daily and seven, 1200 \u03bcg or more daily. There were two dropouts, one due to local side effects and one to a severe pulmonary eosinophilia. Ten patients had local side effects in the form of hoarseness and\/or sore throat, and 13 patients had steroid withdrawal symptoms such as arthralgia and myalgia. The asthma conditon in all patients was improved, as indicated by the reduced need for hospital admissions. The results indicate that high doses of budesonide should be tried before starting maintenance therapy with oral steroids.<\/jats:p>","DOI":"10.1111\/j.1398-9995.1985.tb04155.x","type":"journal-article","created":{"date-parts":[[2007,5,13]],"date-time":"2007-05-13T23:36:31Z","timestamp":1179099391000},"page":"58-64","source":"Crossref","is-referenced-by-count":43,"title":["High Dose Inhaled Budesonide in the Treatment of Severe Steroid\u2010Dependent Asthmatics"],"prefix":"10.1111","volume":"40","author":[{"given":"E.","family":"\u00c4DELROTH","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"ROSENHALL","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"GLENNOW","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,4,28]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.2.6203.1479"},{"issue":"122","key":"e_1_2_1_3_2","article-title":"Development of new glucorticosteroids with a very high ratio between topical and systemic activities","volume":"63","author":"Brattsand R.","year":"1982","journal-title":"Eur. J. Respir.Dis."},{"key":"e_1_2_1_4_2","first-page":"469","article-title":"British Thoracic and Tuberculosis Association: Inhaled corticosteroids compared with oral prednisone in patients starting long\u2010term coricosteroid therapy for asthma","volume":"2","year":"1975","journal-title":"Lancet"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/0007-0971(76)90013-9"},{"key":"e_1_2_1_6_2","first-page":"585","article-title":"Beclomethasone dipropionate","volume":"1","author":"Brown H.","year":"1972","journal-title":"A new steroid for the treatment of allergic asthma. Br. Med. J."},{"key":"e_1_2_1_7_2","first-page":"66","volume-title":"Topical steroid treatment for asthma and rhinitis","author":"Brown H. M.","year":"1980"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.4.5886.205"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(80)90358-7"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/0007-0971(81)90049-8"},{"key":"e_1_2_1_11_2","first-page":"592","article-title":"Long term treatment of patients with perennial bronchial asthma with beclomethasone dipropionate aerosol: A 24\u2010months\u2010follow up study","volume":"22","author":"Johannesson H.","year":"1979","journal-title":"Curr. Ther. Res."},{"issue":"122","key":"e_1_2_1_12_2","article-title":"Topical and systemic glucocorticoid potencies of budesonide, beclomethasone dipropionate and prednisolone in man","volume":"63","author":"Johansson S. \u00c5.","year":"1982","journal-title":"Eur. J. Respir. Dis."},{"key":"e_1_2_1_13_2","first-page":"56","article-title":"Improved aerosol therapy of asthma: Effect of actuator tube size on drug availability","volume":"61","author":"Lindgren S. B.","year":"1980","journal-title":"Eur. J. Respir. Dis."},{"key":"e_1_2_1_14_2","first-page":"317","article-title":"Deposition of pressurized aerosols inhaled through extension devices","volume":"124","author":"Newman S.","year":"1981","journal-title":"Am. Rev. Respir. Dis."},{"issue":"122","key":"e_1_2_1_15_2","article-title":"Comparison between inhaled and oral corticosteroids in patients with chronic asthma","volume":"63","author":"Rosenhall L.","year":"1982","journal-title":"Eur. J. Respir. Dis."},{"issue":"122","key":"e_1_2_1_16_2","article-title":"Pharmacokinetics and metabolism of budesonide, a selective glucocorticoid","volume":"63","author":"Ryrfeldt A.","year":"1982","journal-title":"Eur. J. Respir. Dis."},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/0007-0971(79)90028-7"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(83)91686-0"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-6749(80)90200-6"},{"issue":"122","key":"e_1_2_1_20_2","first-page":"100","article-title":"Clinical use of spacer systems for corticosteroid inhalation therapy","volume":"63","author":"Toogood J. H.","year":"1982","journal-title":"A preliminary analysis. Eur. J. Respir. Dis."},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/0007-0971(76)90004-8"},{"issue":"122","key":"e_1_2_1_22_2","article-title":"Twice daily inhalation of a new corticosteroid, budesonide, in the treatment of chronic asthma","volume":"63","author":"Willey R. F.","year":"1982","journal-title":"Eur. J. Respir. Dis."},{"key":"e_1_2_1_23_2","unstructured":"\u00c4delroth E.&Rosenhall L.:High dose inhaled budesonide and the adrenal function. Under preparation."}],"container-title":["Allergy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1398-9995.1985.tb04155.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1398-9995.1985.tb04155.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T19:11:21Z","timestamp":1697829081000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1398-9995.1985.tb04155.x"}},"subtitle":["A Two\u2010Year Study."],"short-title":[],"issued":{"date-parts":[[1985,1]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1985,1]]}},"alternative-id":["10.1111\/j.1398-9995.1985.tb04155.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1398-9995.1985.tb04155.x","archive":["Portico"],"relation":{},"ISSN":["0105-4538","1398-9995"],"issn-type":[{"value":"0105-4538","type":"print"},{"value":"1398-9995","type":"electronic"}],"subject":[],"published":{"date-parts":[[1985,1]]}}}